Iconovo AB (publ)
STO: ICO.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Anders Mansson
- Employees
- 26
- Headquarters
- Lund, Sweden
- IPO year
- 2018
- Market cap
- SEK 60.6M
- Website
- https://www.iconovo.se
Loading ICO…
Loading profile data…Frequently asked questions about ICO
What does Iconovo AB (publ) (ICO.ST) do?
Iconovo AB (publ) develops and licenses inhalation devices in Sweden. It develops ICOres, a flexible multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler, as well as provides customized inhalation solutions. It serves generic c...
Where does ICO.ST trade?
Iconovo AB (publ) (ICO.ST) trades on the Stockholm Stock Exchange.
What sector is ICO.ST in?
Iconovo AB (publ) (ICO.ST) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Iconovo AB (publ)?
Anders Mansson is the chief executive officer of Iconovo AB (publ) (ICO.ST).
Where is Iconovo AB (publ) headquartered?
Iconovo AB (publ) is headquartered in Sweden.
Does ICO.ST pay a dividend?
Iconovo AB (publ) (ICO.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ICO.ST go public?
Iconovo AB (publ) (ICO.ST) completed its initial public offering in 2018.